Wishing you all the joys of the season! 
Middle East & Africa In-Vitro Diagnostics Market Forecast to 2030
Middle East & Africa In-Vitro Diagnostics Market Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic Fuels Middle East & Africa In-Vitro Diagnostics Market
Point-of-care testing (POCT) is a pivotal opportunity in the in vitro diagnostics market, revolutionizing healthcare delivery with its potable and rapid diagnostic capabilities. These tests, conducted at or near the patient’s location, offer immediate results, enabling timely clinical decision-making. Several factors drive the growth of POCT.
Firstly, the demand for convenient and swift diagnostic solutions in healthcare settings, such as emergency rooms, clinics, and home care, propels the expansion of POCT. Secondly, technological advancements have led to the development of compact and user-friendly POCT devices.
Moreover, the COVID-19 pandemic underscored the significance of rapid and accessible diagnostics. The pandemic accelerated the deployment and utilization of point-of-care COVID-19 tests, showcasing the relevance and potential of POCT in managing infectious diseases on a global scale. This experience accelerated research and development on POCT, further driving innovation and investment in portable testing solutions.
IVDs that are used in the diagnosis of infectious diseases include immunoassays, and molecular assays. Diagnostics companies also focus on making rapid advancements in their offerings to manage COVID-19. Further, regulatory authorities introduced temporary amendments or modifications to their standards, which favored the launches of new IVDs during the pandemic. The demand for molecular diagnostics and immunoassays surged due to these government initiatives. Thus, the COVID-19 pandemic has benefitted the in-vitro diagnostics market due to the rising demand for point-of-care (POC) diagnostics and laboratory testing procedures.
Middle East & Africa In-Vitro Diagnostics Market Overview
The Middle East & Africa in-vitro diagnostics market has been segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. The market growth in Saudi Arabia is highly attributed to the big pool of diabetic population in the country, and government investment in healthcare. South Africa holds second largest share in terms of higher prevalence of chronic disorders in the country. The aforementioned factors are responsible for influential growth of in-vitro diagnostics market in the Middle East & Africa region. The government of Saudi Arabia is taking constructive steps to deal with the higher prevalence of chronic conditions and to fulfil the demand of a huge patient pool. The increasing incidence of cardiovascular diseases and infections is attracting major market players in the country to strengthen customer reach and increase geographic presence. As per a report published by the Saudi Health Council (2023), CVD cases in Saudi Arabia are expected to increase by approximately 480,000 people by 2035, with a threefold increase in economic burden (US$ 9.8 billion). Patients with the highest risk of CVD belong to the age group of 61–75 years, with a prevalence of nearly 49%. Of the moderate to high-risk patients, males have a larger prevalence of around 33% compared to 17% reported in females. As per the World Health Organization report, it is estimated that about 37% of deaths from noncommunicable diseases among people of all ages are caused by CVD in Saudi Arabia.
Early disease diagnosis, increasing healthcare investments, and rising high-tech adoption supporting advanced device manufacturing support the in-vitro diagnostics market growth in Saudi Arabia. As per a report published by the International Trade Administration of the US Department of Commerce (2022), the Saudi Arabian Government plans to invest over US$ 65 billion in the development of its healthcare infrastructure. It also aims to raise private sector contribution from 40% to 65% by 2030, targeting the privatization of 2,300 primary health centers and 290 hospitals. The increasing number of laboratories and healthcare facilities is likely to create a lucrative environment for the growth of the in-vitro diagnostics market in Saudi Arabia. The impact of emerging trends, such as point-of-care testing (POCT), integration of digital health, and the role of artificial intelligence (AI) in diagnostics are also expected to fuel the market growth. Over the next three years, Lunit will provide the “Lunit Insight MMG” AI-based breast cancer diagnostic solution to HMG, which will be used for breast cancer screening in Saudi Arabia. Thus, such developments in diagnostics boost the in-vitro diagnostics market in Saudi Arabia.
Middle East & Africa In-Vitro Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa In-Vitro Diagnostics Market Segmentation
The Middle East & Africa in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.
Based on product & services, the Middle East & Africa in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the Middle East & Africa in-vitro diagnostics market in 2022.
Based on technology, the Middle East & Africa in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the Middle East & Africa in-vitro diagnostics market in 2022.
Based on application, the Middle East & Africa in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the Middle East & Africa in-vitro diagnostics market in 2022.
Based on end user, the Middle East & Africa in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held the largest share of the Middle East & Africa in-vitro diagnostics market in 2022.
Based on country, the Middle East & Africa in-vitro diagnostics market is segmented int o Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa in-vitro diagnostics market in 2022.
Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Middle East & Africa in-vitro diagnostics market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to The Research Team’ research, the Middle East & Africa in-vitro diagnostics market was valued at US$ 3,586.82 million in 2022 and is expected to reach US$ 5,251.59 million by 2030, registering a CAGR of 4.9% from 2022 to 2030. Growth in point-of-care testing and surge in demand for IVD during Covid-19 pandemic and increasing prevalence of chronic and infectious diseases are among the critical factors attributed to the Middle East & Africa in-vitro diagnostics market expansion.
The world is witnessing an exponential increase in the prevalence of infectious diseases. These diseases are prominently caused due to pathogenic microorganisms, such as viruses, bacteria, and parasites. Factors such as poor sanitary conditions, lack of public hygiene, elevating levels of air pollution, and unavailability of safe drinking water play a significant role in the bolstering prevalence of infectious diseases.
Chronic diseases prominently include cancer, chronic respiratory diseases, diabetes, and heart disease. The incidences of these conditions are skyrocketing globally due to biological risk factors, such as an increase in alcohol and tobacco consumption, adoption of unhealthy diets, lack of physical activity, and prevalence of obesity. Chronic conditions are the leading cause of mortality globally.
Estimates published in the 2022 National Diabetes Statistics Report by the World Health Organization state that ~422 million people worldwide have diabetes, the majority living in low-and middle-income countries. Moreover, 1.5 million deaths are directly related to diabetes each year. overweight, genetic conditions, aging, sedentary lifestyle, etc., are boosting the prevalence of diabetes. Hence, the rising prevalence of infectious and chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory conditions drives the growth of the in-vitro diagnostics market.
On the contrary, cumbersome reimbursement procedures and stringent regulations regarding products hamper the Middle East & Africa in-vitro diagnostics market.
Based on product & services, the Middle East & Africa in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held 79.0% share of Middle East & Africa in-vitro diagnostics market in 2022, amassing US$ 2,832.18 million. It is projected to garner US$ 4,189.49 million by 2030 to expand at 5.0% CAGR during 2022–2030.
Based on technology, the Middle East & Africa in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held 28.1% share of Middle East & Africa in-vitro diagnostics market in 2022, amassing US$ 1,006.48 million. It is projected to garner US$ 1,535.59 million by 2030 to expand at 5.4% CAGR during 2022–2030.
Based on application, the Middle East & Africa in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held 39.2% share of Middle East & Africa in-vitro diagnostics market in 2022, amassing US$ 1,407.53 million. It is projected to garner US$ 2,100.03 million by 2030 to expand at 5.1% CAGR during 2022–2030.
Based on end user, the Middle East & Africa in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held 48.9% share of Middle East & Africa in-vitro diagnostics market in 2022, amassing US$ 1,754.38 million. It is projected to garner US$ 2,502.02 million by 2030 to expand at 4.5% CAGR during 2022–2030.
Based on country, the Middle East & Africa in-vitro diagnostics market has been categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 35.3% share of Middle East & Africa in-vitro diagnostics market in 2022. It was assessed at US$ 1,267.62 million in 2022 and is likely to hit US$ 1,830.30 million by 2030, exhibiting a CAGR of 4.7% during 2022–2030.
Key players operating in the Middle East & Africa in-vitro diagnostics market are Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa In-Vitro Diagnostics Market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa In-Vitro Diagnostics Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa In-Vitro Diagnostics Market – Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
4.1.2 Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic
4.2 Market Restraint
4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
4.3 Market Opportunities
4.3.1 Integration of IVD with Digital Health Technologies
4.4 Future Trends
4.4.1 Increasing Demand for Personalized Medicine and Genomics
5. In-Vitro Diagnostics Market – Middle East & Africa Market Analysis
5.1 Middle East & Africa In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 – 2030
6. Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services
6.1 Overview
6.2 Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
6.3 Reagents and Kits
6.3.1 Overview
6.3.2 Reagents and Kits: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Software and Services
6.4.1 Overview
6.4.2 Software and Services: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Instruments
6.5.1 Overview
6.5.2 Instruments: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Technology
7.1 Overview
7.2 Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Immunoassay/ Immunochemistry
7.3.1 Overview
7.3.2 Immunoassay/ Immunochemistry: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Clinical Chemistry
7.4.1 Overview
7.4.2 Clinical Chemistry: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Molecular Diagnostics
7.5.1 Overview
7.5.2 Molecular Diagnostics: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Microbiology
7.6.1 Overview
7.6.2 Microbiology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Blood Glucose Self-Monitoring
7.7.1 Overview
7.7.2 Blood Glucose Self-Monitoring: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Coagulation and Hemostasis
7.8.1 Overview
7.8.2 Coagulation and Hemostasis: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Hematology
7.9.1 Overview
7.9.2 Hematology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.10 Urinalysis
7.10.1 Overview
7.10.2 Urinalysis: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Infectious Disease
8.3.1 Overview
8.3.2 Infectious Diseases: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Diabetes
8.4.1 Overview
8.4.2 Diabetes: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Oncology
8.5.1 Overview
8.5.2 Oncology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Autoimmune Diseases
8.7.1 Overview
8.7.2 Autoimmune Diseases: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Nephrology
8.8.1 Overview
8.8.2 Nephrology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratories
9.4.1 Overview
9.4.2 Laboratories: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Middle East & Africa In-Vitro Diagnostics Market
10.1.1 Overview
10.1.2 Middle East & Africa In-Vitro Diagnostics Market, by Country
10.1.2.1 South Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 South Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.1.4 South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.1.5 South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.1.6 South Africa: Middle East & Africa In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.2 Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.2.4 Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.2.5 Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.2.6 Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.3 UAE: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 UAE: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 UAE: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.3.4 UAE: Middle East & Africa In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.3.5 UAE: Middle East & Africa In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.3.6 UAE: Middle East & Africa In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.2.4 Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.3 Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
10.1.2.4.4 Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
10.1.2.4.5 Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
10.1.2.4.6 Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11. Industry Landscape
11.1 Organic Developments
11.1.1 Overview
11.2 Inorganic Developments
11.2.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Siemens AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sysmex Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 bioMerieux SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Qiagen NV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa In-Vitro Diagnostics Market Segmentation
Table 2. South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 3. South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 4. South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. South Africa: Middle East & Africa In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9. Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. UAE: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 11. UAE: Middle East & Africa In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 12. UAE: Middle East & Africa In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. UAE: Middle East & Africa In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Organic Developments Done by Companies
Table 19. Inorganic Developments Done by Companies
Table 20. Glossary of Terms, Middle East & Africa In-Vitro Diagnostics Market
LIST OF FIGURES
Figure 1. Middle East & Africa In-Vitro Diagnostics Market Segmentation, By Country
Figure 2. Middle East & Africa In-Vitro Diagnostics Market: Key Industry Dynamics
Figure 3. Middle East & Africa In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 6. Reagents and Kits: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Software and Services: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Instruments: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 10. Immunoassay/ Immunochemistry: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Clinical Chemistry: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular Diagnostics: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Microbiology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Blood Glucose Self-Monitoring: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Coagulation and Hemostasis: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Hematology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Urinalysis: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
Figure 20. Infectious Diseases: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Diabetes: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Oncology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Cardiology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Autoimmune Diseases: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Nephrology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Laboratories: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Homecare: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 33. Middle East & Africa In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 34. South Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. UAE: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
The List of Companies – Middle East & Africa In-Vitro Diagnostics Market
o Abbott Laboratories
o F. Hoffmann-La Roche Ltd
o Danaher Corp
o Siemens AG
o Sysmex Corp
o Thermo Fisher Scientific Inc
o Becton Dickinson and Co
o bioMerieux SA
o Bio-Rad Laboratories Inc
o Qiagen NV
You must be logged in to post a review.
Reviews
There are no reviews yet.